(Q40792999)

English

Multicenter evaluation of the antimicrobial activity for seven broad-spectrum beta-lactams in Turkey using the Etest method. Turkish Antimicrobial Resistance Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Multicenter evaluation of the antimicrobial activity for seven broad-spectrum beta-lactams in Turkey using the Etest method. Turkish Antimicrobial Resistance Study Group (English)

1 reference

Europe PubMed Central

23 September 2017

multicenter clinical trial

0 references

3

object named as

Jones RN

1 reference

Europe PubMed Central

23 September 2017

Michael A. Pfaller

1

object named as

Pfaller MA

1 reference

Europe PubMed Central

23 September 2017

author name string

Korten V

2

1 reference

Europe PubMed Central

23 September 2017

Doern GV

4

1 reference

Europe PubMed Central

23 September 2017

publication date

1 September 1999

1 reference

Europe PubMed Central

23 September 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

23 September 2017

35

1 reference

Europe PubMed Central

23 September 2017

1

1 reference

Europe PubMed Central

23 September 2017

65-73

1 reference

Europe PubMed Central

23 September 2017

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the E test, a novel method of quantifying antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The evolution of resistance to cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from eighteen Brazilian hospitals by using the Etest

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900054-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(99)00054-1

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40792999&oldid=1959536060"